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Prognostic Factors for the Success of Laser Iridotomy for 
Acute Primary Angle Closure Glaucoma
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CHEIL Eye Hospital, Daegu, Korea
Purpose: To identify the prognostic factors for successful laser iridotomy for acute angle-closure glaucoma (AACG).
Methods: We retrospectively reviewed the medical records of 77 eyes of 77 patients with AACG with initial intraocular 
pressure (IOP) above 40 mmHg. All of the patients received maximum tolerable medical therapy (MTMT) followed by 
laser iridotomy. In order to comparatively analyze the factors affecting successful laser iridotomy, an increase in IOP 
on follow-up was defined as increase in IOP greater than 21 mmHg requiring medical or surgical treatment.
Results: Successful laser iridotomy was achieved in 59.7% (46/77 eyes). Thirty-one eyes (40.3%) exhibited increased 
IOP on follow-up, and of these, 30 eyes developed an increase in IOP within six months after the first attack. The 
success rate was higher (92.9%) in 42 patients who had greater than 30% IOP reduction by MTMT at the first attack 
compared to the 35 patients whose IOP reduction was less than 30%, of which 24 eyes (72.7%) showed more than 
30% IOP reduction after intravenous hyperosmotic agent treatment (p=0.012). The success rate was higher in patients 
treated within seven days after the development of symptoms than in those treated after seven days (Odds ratio, 
4.51; 95% confidence interval, 1.38 to 14.75).
Conclusions: Our data suggest that we can expect successful IOP control after laser iridotomy in eyes with AACG 
if the patient can be treated within seven days after the development of symptoms and if the IOP reduction was 
more than 30% by MTMT.
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Laser iridotomy is performed primarily for the treatment 
of acute angle-closure glaucoma (AACG) caused by relative 
pupillary block. Laser iridotomy offers the same efficacy as 
surgical iridectomy with fewer complications and can be 
easily and quickly performed in outpatient departments.
1-6 
Iridotomy helps to prevent AACG by flattening the convex 
surface of the iris and widening the angle in patients with 
relative pupillary block. Success rates of laser iridotomy 
have been reported to be from 65-76%,
7,8 and are relatively 
low in patients of east Asian descent.
9
Identifying factors associated with successful laser iri-
dotomy for patients with AACG would be quite helpful 
in designing a proper treatment plan for each patient after 
laser iridotomy.
The present research examined a sample of Korean pa-
tients with AACG with corneal edema and with IOP above 
40 mmHg as there is a lower response to pilocarpine caused 
by the ischemia of the iris above this level of intraocular 
pressure (IOP).
10 Therefore, it may be more difficult to per-
form successful laser iridotomy in these eyes and achieve 
appropriate IOP. Maximum tolerable medical therapy was 
administered to all subjects and the response to therapy and 
relevant clinical factors that may affect IOP control after laser 
iridotomy were collected and analyzed.
Materials and Methods
The subjects were selected from patients who visited 
CHEIL Eye Hospital during the period from June 2004 to 
June 2008 and presented with AACG with initial IOP above 
40 mmHg at the time of visiting the hospital. Based on me-
dical records, a retrospective review was carried out using 
77 eyes of 77 patients. None of the patients included in the 
study had a pathological condition affecting the visual field 
except transient changes after acute glaucoma such as non-
specific constriction. Patients who had previously been trea-
ted for any glaucoma were excluded. Also, secondary angle- 
closure glaucoma such as neovascular glaucoma, lens-induced 
glaucoma and uveitic glaucoma were specifically excluded.
AACG was diagnosed when the eye showed an IOP more 
than 40 mmHg and closed angle by gonioscopy with accom-
panying acute symptoms including ocular pain, redness and 
blurred vision according to Kim and Jung’s classification 
system.
11 At the time of first visit, all patients immediately 
received β-blocker drops and 2% pilocarpine in the eyes, 
along with oral administration of a carbonic anhydrase in-JW Lee, et al. THE SUCCESSFUL LASER IRIDOTOMY FOR AACG
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Table 1. Patient demographics
Variables Values
(N=77)
Male : Female  18 : 59
Age (yr) 66.0 (30-84)
Baseline intraocular pressure (mmHg)  52.6 (40-80)
Follow-up (mon) 12.7 (1-48)
Table 2. Time interval to increase intraocular pressure (IOP) after successful laser iridotomy (77 eyes)
Outcome No. of eyes %
Eyes with no subsequent increase in IOP after laser iridotomy 46  59.7
Eyes with subsequent increase in IOP after laser iridotomy 
(duration after laser iridotomy) 
   Total 31 40.3
   ≤1 mon 20 26.0
   1 mon to 3 mon 7 9.1
   3 mon to 6 mon 3 3.9
   >6 mon 1 1.3
hibitor. Intravenous hyperosmotic agent (15% Mannitol
®; 
Choongwae Pharmaceutical Co., Seoul, Korea) was given 
if the patient did not have a significant systemic disease, 
such as acute intra-cranial hematoma or severe congestive 
heart failure. Laser iridotomy was performed immediately 
after the resolution of corneal edema and the widening of 
the angle.
Laser iridotomy was performed with an argon laser (Integre- 
S; Ellex Medical Pty. Ltd., Adelaide, Australia) and Nd:YAG 
laser (YC-1800; NIDEK, Gamagori, Japan) by a single 
operator on all patients, in order to minimize interobserver 
error. 0.5% proparacaine HCl and 1% apraclonidine were 
dropped into the eye prior to surgery, and then an Abraham 
iridotomy lens was inserted into the eye to excise the sup- 
erotemporal or superonasal area of the iris. The spot size 
of the argon laser was 50 μm, while the time, strength and 
frequency of the irradiation were 0.05-0.1 second, 900-1000 mW 
and 10-70 times, respectively. When part of the pigmented 
epithelium was seen or when the iris stroma was sufficiently 
removed for the pigmented epithelium to be exposed, 
Nd:YAG laser irradiation was applied  3-25  times  at  2.3-3.4 
mJ. The laser pointer of the argon laser was used to make 
sure the size of the excision area was at least 150-200 μm. 
After surgery, 1% apraclonidine was dropped into the eye 
and then 0.1% fluorometholone was administered four times 
a day for a week. As unaffected eyes have an approximately 
50% acute angle-closure attack probability within five 
years,
2 prophylactic laser iridotomy was performed for the 
other eye during the follow-up observation period.
IOP was measured by Goldmann applanation tonometer 
at the time of the initial hospital visit, 1-2 hours after me-
dical therapy and one hour, one day, three days, one week, 
two weeks, one month and every three months after initial 
laser iridotomy. The success of laser iridotomy was assessed 
in terms of IOP, reduction rate of IOP and the necessity 
of additional treatment. For the purpose of analysis, an in- 
crease in IOP on follow-up was defined as an increase 
greater than 21 mmHg requiring medical or surgical treat-
ment. The time intervals to increases in IOP after laser iri-
dotomy were recorded. 
We analyzed the data to detect whether there were pre-
dictive factors for development of IOP increase, such as 
age, sex of the patient, duration of symptoms, initial levels 
of IOP and pupil status. A dilated, fixed, miotic-resistant 
pupil was defined as a pupil greater than 7 mm in diameter 
and not responding to miotics and light even after IOP nor-
malized following treatment as previously described.
Multivariate odds ratio analyses between each risk factors 
and the risk of subsequent increases of IOP after laser iri-
dotomy was carried out. The confidence interval was 95% 
for the odds ratio and statistical significance was assumed 
at  p<0.05.
Results
From June 2004 to June 2008, 77 eyes of 77 patients were 
included in this study. The mean follow-up period was 12.7 
months (range, 1 to 48 months). Of the 77 patients who 
received laser iridotomy, 18 patients were male and 59 were 
female with a mean age of 66.0 years (range, 30 to 84 years). 
The mean duration of symptoms was 6.4 days (range, 1 to 30 
days) and the mean initial IOP was 52.6 mmHg (range, 40 to 80 
mmHg) (Table 1).
All patients underwent sequential argon laser and Nd: 
YAG laser peripheral iridotomy after maximal tolerable me-
dical therapy and all 77 eyes achieved a patent iridotomy of 
sufficient size. Temporary IOP spikes were noted in three 
eyes after laser iridotomy (range, 22 to 32) and all cases 
resolved spontaneously without further treatment within a Korean J Ophthalmol Vol.23, No.4, 2009
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Table 3. Relationship between the amount of intraocular pressure (IOP) reduction after maximal tolerable medical 
therapy and risk of developing a subsequent increase in IOP after successful laser iridotomy




Not further treatment required Additional treatment required
Maximal tolerable medical therapy
   ≥30% 39 3
   <30%  7 28 0.000
Mannitolization
   ≥30% 24 9
   <30%  5 11 0.012
* Fisher’s exact test.
Table 4. Relationship between selected factors and risk of developing a subsequent increase in intraocular pressure 
(IOP) after successful laser iridotomy
Risk factors
Additional treatment required
Odds ratio 95% confidence interval
Not further treatment required Additional treatment required
Sex
   Male 10 8 0.80 0.28-2.32
   Female 36 23
Age
   ≤60 yr 14 7 1.50 0.53-4.29
   >60 yr 32 24
Duration of symptoms
   ≤7 days 41 20 4.51 1.38-14.75
   >7 days 5 11
IOP
   ≤50 mmHg 24 12 1.73 0.68-4.36
   >50 mmHg 22 19
Dilated fixed pupil
   Yes 0 8
   No 46 23 0.000
*
* Fisher’s exact test.
day. There were no severe complications accompanying the 
laser iridotomy such as retinal burn, corneal injury, hyphema 
and intractable inflammations.
The time interval for the subsequent increase in IOP is 
shown in Table 2. Forty-six of 77 eyes (59.7%) had nor-
malized IOP on follow-up after laser iridotomy alone. Thirty- 
one of 77 eyes developed an increase in IOP during follow- 
up and most of them (30/31 eyes) presented an increased 
IOP within six months after laser iridotomy. In this group, 
20 of 31 eyes developed an early increase in IOP within 
one month after laser iridotomy.
The mean IOP was 32.1±26.9 mmHg (range, 22 to 60 
mmHg) in 31 eyes showing IOP increases after laser iridot-
omy and two eyes eventually underwent trabeculectomy in 
order to achieve IOP control.
We evaluated successful laser iridotomy according to the 
response of the maximal tolerable medical therapy given 
immediately upon hospital visit. The IOP of 42 of 77 eyes was 
reduced to more than 30% of the initial IOP, of which 39 of 42 
eyes had not developed an increase in IOP during follow-up. 
However, in the 35 eyes presenting with less than 30% IOP 
reduction after maximal tolerable medical therapy, only 
seven of 35 eyes had not developed an increase in IOP 
(p=0.000) (Table 3). Forty-nine of 77 eyes were administered 
intravenous hyperosmotic agent treatment during maximal 
tolerable medical therapy and there was no IOP increase in 24 
of the 49 eyes (p=0.012) on follow-up (Table 3). 
We evaluated five possible predictive factors for the de-
velopment of a subsequent increase in IOP requiring further 
treatment: age, sex of the patient, duration of symptoms, 
level of initial IOP and pupil status. Successful laser irido-
tomy was more often achieved in patients who presented 
within seven days (Odds ratio, 4.51; 95% confidence interval, 
1.38 to 14.75). Patients who were female, older than 60 years, 
and had initial IOP above than 50 mmHg were found to have a 
greater chance of developing an increase in IOP although not 
statistically significant. Dilated fixed pupils were observed 
only in eyes presenting with an increase in IOP after laser 
iridotomy (p=0.000) (Table 4).JW Lee, et al. THE SUCCESSFUL LASER IRIDOTOMY FOR AACG
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Discussion
The success rate of laser iridotomy is influenced by the 
length of follow-up period.
12-14 Re-opening the closed angle 
is the major goal in the treatment of AACG. Reduction of 
IOP also helps to prevent further glaucomatous damage. 
There are several methods used to achieve re-opening in-
cluding medical therapy, corneal indentation, laser iridoplasty 
or pupilloplasty, and laser iridotomy. If there is no response 
to these treatments, surgical iridectomy or trabeculectomy is 
indicated. Primary treatment usually starts with IOP-reducing 
drugs followed by laser iridotomy performed promptly once 
the attack has been resolved by medical therapy. In most 
cases, laser iridotomy relieves the AACG attack. We analyzed 
the predictive values of several factors for successful laser 
iridotomy to provide better pre-iridotomy patient assessment 
in the future.
The present study showed that there were no differences 
in the success rates of laser iridotomy according to sex, age 
and initial IOP which agrees with the results of research 
conducted by Chung et al.
12 and Aung et el.
13 Forty-six of 
110 eyes (41.8%) in Aung et al.
13, 32 of 45 eyes (71.1%) 
in Chung et al.
12 and 46 of 77 eyes (59.7%) in the present 
study were treated with laser peripheral iridotomy alone with 
no subsequent increase in IOP at follow-up. Laser irido-
tomy alone is, however, not sufficient to prevent a clinically 
significant increase in IOP after AACG in the majority of 
patients of east Asian descent.
13 In addition, IOP after laser 
iridotomy usually increases within six months in Asian eyes 
treated with AACG.
12,13 These findings are unique in Asians.
13 
Several reasons have been suggested for this marked ethnic 
difference in IOP increases with AACG. Oh et al.
15 empha-
sized geographical variation in the chamber angle - the iris 
joins the scleral wall more anteriorly in east Asians and 
more posteriorly in individuals of European descent. Kim 
and Jung
11 also mentioned that creeping angle closure is 
not uncommon, and that anterior lens positioning without 
significant lens enlargement is responsible for angle-closure 
glaucoma in Asians. Aung et al.
13 reported that Asian eyes 
may be prone to develop more severe attacks of acute pri-
mary angle-closure compared to Europeans, and that this 
may be related to the longer duration of symptoms and 
the difficulty of breaking the acute attack. In addition, more 
laser energy is needed to penetrate the iris for iridotomy 
performed on the thicker dark-brown irides common in 
Asians.
13,16 The trabecular meshwork’s damage and dimi-
nished outflow caused by inflammation and pigment release 
during laser iridotomy with higher laser energy level may 
ultimately cause increased IOP on follow-up.
13 Therefore, 
it is necessary to monitor IOP closely in the first few months 
after AACG in order to manage subsequent increases in IOP.
The success rates were analyzed in terms of response to 
maximal tolerable medical therapy given immediately upon 
the initial hospital visit. Out of 42 eyes with more than 
30% IOP reduction, the IOP of 39 patients (92.9%) were 
normalized with laser iridotomy alone. Of the 35 patients 
with lower than 30% IOP reduction, only seven eyes were 
satisfactorily controlled. Higher rates of successful laser iri-
odotomy were achieved in eyes with more than 30% reduced 
IOP upon maximal tolerable medical therapy (p<0.001). We 
considered those who showed a significant IOP reduction 
effect with medical therapy alone to have no significant 
anatomical and functional abnormalities of aqueous outflow, 
therefore maintaining appropriate IOP after laser iridotomy. 
In addition, of those patients who received intravenous 
Mannitol
®  (systemic mannitolization) as a part of medical 
therapy, 24 of 33 eyes (72.7%) with more than 30% reduced 
IOP had not developed an increase in IOP, while only five 
of 16 patients with less than 30% reduced IOP did not 
experience an increase (p=0.012). Systemic mannitolization 
causes a reduction in vitreous volume, thereby aiding the 
reduction of IOP through the angle-closure alleviation effect 
and pupillary block alleviation effect. We believe that this 
is why those patients with more than 30% IOP reduction 
upon systemic mannitolization showed a significantly higher 
success rate, since IOP was maintained appropriately after 
the laser iridotomy.
An increase in IOP was observed more frequently in 
eyes treated more than seven days after the development 
of symptoms. A longer duration of symptoms may cause 
more damages to aqueous outflow and lead to the formation 
of peripheral anterior synechiae (PAS).
17 AACG and chronic 
angle-closure glaucoma are most likely to have a greater 
extent of PAS than patients in the angle closure hypertension 
or ACG suspect subtypes. In addition, synechial closure of 
the  angle  may  play  an  important role in IOP increases in 
later disease stages. Such a difference is thought to increase the 
risk of PAS occurrence as the angle-closure glaucoma  period 
gets longer and to cause the functional loss of aqueous humor 
outflow. A dilated and fixed pupil was already mentioned 
as a possible factor related to laser iridotomy failure due to 
accelerated PAS formation
18 and dilated, fixed pupils  were 
only observed in eyes presenting an increase in IOP in this 
study. 
In conclusion, the present research demonstrates that the 
success rate of laser iridotomy is not related to age, sex or 
initial IOP. Successful laser iridotomy was achieved in eyes 
treated within seven days of acute symptom onset, and cases 
with more than 30% reduced IOP upon maximal tolerable 
medical therapy including systemic mannitolization had a 
significantly higher success rate compared to laser iridotomy 
alone. We believe that this result is helpful in developing 
treatment modalities for AACG patients. 
A limitation of the present research is that it was a 
hospital-based retrospective study. Analyses of additional 
features such as the degree of distribution of the PAS and 
the size of the pupil at the time of attack would be helpful 
in future studies. Further research with long-term follow-up 
observation of eyes after successful laser iridotomy and with 
appropriate IOP control with respect to the recurrence and 
progression of acute angle-closure glaucoma is warranted.Korean J Ophthalmol Vol.23, No.4, 2009
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